- Home
- DTIL vs CEE Comparison
DTIL vs CEE Comparison
Compare DTIL & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | CEE |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 101.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | DTIL | CEE |
|---|---|---|
| Price | $4.05 | $18.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | ★ 235.6K | 22.0K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $698,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $34.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.61 | $7.80 |
| 52 Week High | $8.82 | $10.32 |
Technical Indicators
Market Signals| Indicator | DTIL | CEE |
|---|---|---|
| Relative Strength Index (RSI) | 30.63 | 64.57 |
| Support Level | $4.14 | $17.47 |
| Resistance Level | $4.43 | $18.46 |
| Average True Range (ATR) | 0.26 | 0.58 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 8.30 | 77.20 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.